2,732
Views
4
CrossRef citations to date
0
Altmetric
Reviews

Virulence and molecular adaptation of human urogenital mycoplasmas: a review

, &
Pages 689-698 | Received 05 Dec 2018, Accepted 04 Apr 2019, Published online: 02 May 2019

References

  • Roachford OSE, Nelson KE, Mohapatra BR. A novel approach for the identification and phylogenetic delineation of human Mycoplasma species and strains using genomic segment sequence analysis. Infect Genet Evol. 2019;68:68–76.
  • Andreev J, Borovsky Z, Rosenshine I. Invasion of HeLa cells by Mycoplasma penetrans and the induction of tyrosine phosphorylation of a 145-kDa host cell protein. FEMS Microbiol Lett. 1995;132:189–194.
  • Girón JA, Lange M, Baseman JB. Adherence, fibronectin binding, and induction of cytoskeleton reorganization in cultured human cells by Mycoplasma penetrans. Infect Immun. 1996;64:197–208.
  • Hopfe M, Deenen R, Degrandi D, et al. Host cell responses to persistent mycoplasmas—different stages in infection of HeLa cells with Mycoplasma hominis. PLoS One. 2013;8:e54219.
  • Ladefoged SA, Birkelund S, Hauge S, et al. A 135-kilodalton surface antigen of Mycoplasma hominis PG21 contains multiple directly repeated sequences. Infect Immun. 1995;63:212–223.
  • Rottem S. Interaction of mycoplasmas with host cells. Physiol Rev. 2003;83:417–432.
  • Razin S, Yogev D, Naot Y. Molecular biology and pathogenicity of mycoplasmas. Microbiol Mol Biol Rev. 1998;62:1094–1156.
  • Razin S. The prokaryotes: a handbook on the biology of bacteria. 3rd ed. Vol. 4, Bacteria: Firmicutes, Cyanobacteria. New York (NY): Springer; 2006.
  • Ma L, Jensen JS, Myers L, et al. Mycoplasma genitalium: an efficient strategy to generate genetic variation from a minimal genome. Mol Microbiol. 2007;66:220–236.
  • Citti C, Nouvel LX, Baranowski E. Phase and antigenic variation in mycoplasmas. Future Microbiol. 2010;5:1073–1085.
  • Seya T, Matsumoto M. A lipoprotein family from Mycoplasma fermentans confers host immune activation through Toll-like receptor 2. Int J Biochem Cell Biol. 2002;34:901–906. Aug 1
  • Nishiguchi M, Matsumoto M, Takao T, et al. Mycoplasma fermentans lipoprotein M161Ag-induced cell activation is mediated by Toll-like receptor 2: role of N-terminal hydrophobic portion in its multiple functions. J Immunol. 2001;166:2610–2616.
  • Into T, Okada K, Inoue N, et al. Extracellular ATP regulates cell death of lymphocytes and monocytes induced by membrane-bound lipoproteins of Mycoplasma fermentans and Mycoplasma salivarium. Microbiol Immunol. 2002;46:667–675.
  • Di Virgilio F, Schmalzing G, Markwardt F. The elusive P2X7 macropore. Trends Cell Biol. 2018;28:392–404.
  • Baseman JB, Tully JG. Mycoplasmas: sophisticated, re-emerging, and burdened by their notoriety. Emerg Infect Dis. 1997;3:21–32.
  • Falk L, Fredlund H, Jensen JS. Signs and symptoms of urethritis and cervicitis among women with or without Mycoplasma genitalium or Chlamydia trachomatis infection. Sex Transm Infect. 2005;81:73–78.
  • Dehon P, McGowin CL. The immunopathogenesis of Mycoplasma genitalium infections in women: a narrative review. Sex Transm Dis. 2017;44:428–432.
  • Nicolson GL, Nasralla MY, Franco AR, et al. Diagnosis and integrative treatment of intracellular bacterial infections in chronic fatigue and fibromyalgia syndromes, Gulf war illness, rheumatoid arthritis and other chronic illnesses. Clin Pract Altern Med. 2000;1:92–102.
  • Gdoura R, Kchaou W, Chaari C, et al. Ureaplasma urealyticum, Ureaplasma parvum, Mycoplasma hominis and Mycoplasma genitalium infections and semen quality of infertile men. BMC Infect Dis. 2007;7:129.
  • Zarei O, Rezania S, Mousavi A. Mycoplasma genitalium and cancer: a brief review. Asian Pac J Cancer Prev. 2013;14:3425–3428.
  • Wagner PL, Waldor MK. Bacteriophage control of bacterial virulence. Infect Immun. 2002;70:3985–3993.
  • Röske K, Calcutt MJ, Wise KS. The Mycoplasma fermentans prophage phiMFV1: genome organization, mobility and variable expression of an encoded surface protein. Mol Microbiol. 2004;52:1703–1720.
  • Alvarez RA, Blaylock MW, Baseman JB. Surface localized glyceraldehyde-3-phosphate dehydrogenase of Mycoplasma genitalium binds mucin. Mol Microbiol. 2003;48:1417–1425.
  • Henrich B, Hopfe M, Kitzerow A, et al. The adherence-associated lipoprotein P100, encoded by an opp operon structure, functions as the oligopeptide-binding domain OppA of a putative oligopeptide transport system in Mycoplasma hominis. J Bacteriol. 1999;181:4873–4878.
  • Hopfe M, Dahlmanns T, Henrich B. In Mycoplasma hominis the OppA-mediated cytoadhesion depends on its ATPase activity. BMC Microbiol. 2011;11:185.
  • Distelhorst SL, Jurkovic DA, Shi J, et al. The variable internal structure of the Mycoplasma penetrans attachment organelle revealed by biochemical and microscopic analyses: implications for attachment organelle mechanism and evolution. J Bacteriol. 2017;199:e00069–17.
  • Woese CR, Fox GE. Phylogenetic structure of the prokaryotic domain: the primary kingdoms. Proc Natl Acad Sci USA. 1977;74:5088–5090.
  • Weisburg WG, Tully JG, Rose DL, et al. A phylogenetic analysis of the mycoplasmas: basis for their classification. J Bacteriol. 1989;171:6455–6467.
  • Fraser CM, Gocayne JD, White O, et al. The minimal gene complement of Mycoplasma genitalium. Science. 1995;270:397–403.
  • Mushegian AR, Koonin EV. A minimal gene set for cellular life derived by comparison of complete bacterial genomes. Proc Natl Acad Sci USA. 1996;93:10268–10273.
  • Hutchison Iii CA, Petterson SN, Gill SR, et al. Global transposon mutagenesis and a minimal Mycoplasma genome. Science. 1999;286:2165–2169.
  • Glass JI, Assad-Garcia N, Alperovich N, et al. Essential genes of a minimal bacterium. Proc Natl Acad Sci USA. 2006;103:425–430.
  • Gil R, Silva FJ, Peretó J, et al. Determination of the core of a minimal bacterial gene set. Microbiol Mol Biol Rev. 2004;68:518–537.
  • Pereyre S, Sirand-Pugnet P, Beven L, et al. Life on arginine for Mycoplasma hominis: clues from its minimal genome and comparison with other human urogenital mycoplasmas. PLoS Genet. 2009;5:e1000677–e1000613.
  • Roachford OSE, Nelson KE, Mohapatra BR. Comparative genomics of four Mycoplasma species of the human urogenital tract: analysis of their core genomes and virulence genes. Int J Med Microbiol. 2017;307:508–520.
  • Lluch-Senar M, Delgado J, Chen WH, et al. Defining a minimal cell: essentiality of small ORFs and ncRNAs in a genome-reduced bacterium. Mol Syst Biol. 2015;11:780.
  • NCBI Resource Coordinators. Database resources of the National Center for Biotechnology Information. Nucleic Acids Res. 2016;44:D7–D19.
  • García-Morales L, González-González L, Querol E, et al. A minimized motile machinery for Mycoplasma genitalium. Mol Microbiol. 2016;100:125–138.
  • Seybert A, Gonzalez-Gonzalez L, Scheffer MP, et al. Cryo-electron tomography analyses of terminal organelle mutants suggest the motility mechanism of Mycoplasma genitalium. Mol Microbiol. 2018;108:319–329.
  • Pich OQ, Burgos R, Ferrer-Navarro M, et al. Role of Mycoplasma genitalium MG218 and MG317 cytoskeletal proteins in terminal organelle organization, gliding motility and cytadherence. Microbiology. 2008;154:3188–3198.
  • Ruland K, Wenzel R, Herrmann R. Analysis of three different repeated DNA elements present in the P1 operon of Mycoplasma pneumoniae: size, number and distribution on the genome. Nucleic Acids Res. 1990;18:6311–6317.
  • Dhandayuthapani S, Rasmussen WG, Baseman JB. Disruption of gene mg218 of Mycoplasma genitalium through homologous recombination leads to an adherence-deficient phenotype. Proc Natl Acad Sci USA. 1999;96:5227–5232.
  • Peterson SN, Bailey CC, Jensen JS, et al. Characterization of repetitive DNA in the Mycoplasma genitalium genome: possible role in the generation of antigenic variation. Proc Natl Acad Sci USA. 1995;92:11829–11833.
  • Iverson-Cabral SL, Wood GE, Totten PA. Analysis of the Mycoplasma genitalium MgpB adhesin to predict membrane topology, investigate antibody accessibility, characterize amino acid diversity, and identify functional and immunogenic epitopes. PLoS One. 2015;10:e0138244.
  • Dhandayuthapani S, Blaylock MW, Bebear CM, et al. Peptide methionine sulfoxide reductase (MsrA) is a virulence determinant in Mycoplasma genitalium. J Bacteriol. 2001;183:5645–5650.
  • Kitzerow A, Hadding U, Henrich B. Cyto-adherence studies of the adhesin P50 of Mycoplasma hominis. J Med Microbiol. 1999;48:485–493.
  • Hasebe A, Mu H-H, Cole BC. factor from Mycoplasma hominis is a TLR2-dependent, macrophage-activating, P50-related adhesin. Am J Reprod Immunol. 2014;72:285–295.
  • Boesen T, Emmersen J, Jensen LT, et al. The Mycoplasma hominis vaa gene displays a mosaic gene structure. Mol Microbiol. 1998;29:97–110.
  • Boesen T, Fedosova NU, Kjeldgaard M, et al. Molecular design of Mycoplasma hominis Vaa adhesin. Protein Sci. 2001;10:2577–2586.
  • Mandal C, Chatterjee M, Sinha D. Investigation of 9-O-acetylated sialoglycoconjugates in childhood acute lymphoblastic leukaemia. Br J Haematol. 2000;110:801–812.
  • Henrich B, Feldmann RC, Hadding U. Cytoadhesins of Mycoplasma hominis. Infect Immun. 1993;61:2945–2951.
  • Varki A. Sialic acids as ligands in recognition phenomena. FASEB J. 1997;11:248–255.
  • Hamaguchi T, Kawakami M, Furukawa H, et al. Identification of novel protein domain for sialyloligosaccharide binding essential to Mycoplasma mobile gliding. FEMS Microbiol Lett. 2019;366:fnz016.
  • Rosales-Pérez M, Giono-Cerezo S, Girón J, et al. Adherence of a clinical strain of Mycoplasma fermentans to human cultured epithelial cells. Adv Microbiol. 2014;4:726–735.
  • Leigh SA, Wise KS. Identification and functional mapping of the Mycoplasma fermentans P29 adhesin. Infect Immun. 2002;70:4925–4935.
  • Yavlovich A, Katzenell A, Tarshis M, et al. Mycoplasma fermentans binds to and invades HeLa cells: involvement of plasminogen and urokinase. Infect Immun. 2004;72:5004–5011.
  • Yavlovich A, Rechnitzer H, Rottem S. Alpha-enolase resides on the cell surface of Mycoplasma fermentans and binds plasminogen. Infect Immun. 2007;75:5716–5719.
  • Lähteenmäki K, Edelman S, Korhonen TK. Bacterial metastasis: the host plasminogen system in bacterial invasion. Trends Microbiol. 2005;13:79–85.
  • Sasaki Y, Ishikawa J, Yamashita A, et al. The complete genomic sequence of Mycoplasma penetrans, an intracellular bacterial pathogen in humans. Nucleic Acids Res. 2002;30:5293–5300.
  • Ferris SL, Watson H, Neyrolles O, et al. Characterization of a major Mycoplasma penetrans lipoprotein and of its gene. FEMS Microbiol Lett. 1995;130:313–320.
  • Neyrolles O, Chambaud I, Ferris S, et al. Phase variations of the Mycoplasma penetrans main surface lipoprotein increase antigenic diversity. Infect Immun. 1999;67:1569–1578.
  • Iverson-Cabral SL, Astete SG, Cohen CR, et al. mgpB and mgpC sequence diversity in Mycoplasma genitalium is generated by segmental reciprocal recombination with repetitive chromosomal sequences. Mol Microbiol. 2007;66:55–73.
  • Burgos R, Wood GE, Young L, et al. RecA mediates MgpB and MgpC phase and antigenic variation in Mycoplasma genitalium, but plays a minor role in DNA repair. Mol Microbiol. 2012;85:669–683.
  • Ma L, Taylor S, Jensen JS, et al. Short tandem repeat sequences in the Mycoplasma genitalium genome and their use in a multilocus genotyping system. BMC Microbiol. 2008;8:130–142.
  • Rocha EPC, Blanchard A. Genomic repeats, genome plasticity and the dynamics of Mycoplasma evolution. Nucleic Acids Res. 2002;30:2031–2042.
  • Ladefoged SA, Jensen LT, Brock B, et al. Analysis of 0.5-kilobase-pair repeats in the Mycoplasma hominis lmp gene system and identification of gene products. J Bacteriol. 1996;178:2775–2784.
  • Mardassi BBA, Ayari H, Béjaoui-Khiari A, et al. Genetic variability of the P120′ surface protein gene of Mycoplasma hominis isolates recovered from Tunisian patients with uro-genital and infertility disorders. BMC Infect Dis. 2007;7:142.
  • Arraes FBM, de Carvalho MJA, Maranhão AQ, et al. Differential metabolism of Mycoplasma species as revealed by their genomes. Genet Mol Biol. 2007;30:182–189.
  • Reshes G, Vanounou S, Fishov I, et al. Cell shape dynamics in Escherichia coli. Biophys J. 2008;94:251–264.
  • Chien A, Hill NS, Levin PA. Cell size control in bacteria. Curr Biol. 2013;22:1–23.
  • Bocharov G, Ludewig B, Bertoletti A, et al. Underwhelming the immune response: effect of slow virus growth on CD8+-T-lymphocyte responses. J Virol. 2004;78:2247–2254.
  • Gibson DG, Glass JI, Lartigue C, et al. Creation of a bacterial cell controlled by a chemically synthesized genome. Science. 2010;329:52–56.
  • Jan G, Fontenelle C, Le Hénaff M, et al. Acylation and immunological properties of Mycoplasma gallisepticum membrane proteins. Res Microbiol. 1995;146:739–750.
  • Zuo L, Wu Y, You X. Mycoplasma lipoproteins and Toll-like receptors. J Zhejiang Univ Sci B. 2009;10:67–76.
  • Grover RK, Zhu X, Nieusma T, et al. A structurally distinct human Mycoplasma protein that generically blocks antigen-antibody union. Science. 2014;343:656–661.
  • Arfi Y, Minder L, Di Primo C, et al. MIB-MIP is a mycoplasma system that captures and cleaves immunoglobulin G. Proc Natl Acad Sci USA. 2016;113:5406–5411.
  • Lister MF, Sharkey J, Sawatzky D, et al. The role of the purinergic P2X7 receptor in inflammation. J Inflamm. 2007;4:5.
  • Hopfe M, Henrich B. OppA, the ecto-ATPase of Mycoplasma hominis induces ATP release and cell death in HeLa cells. BMC Microbiol. 2008;8:55.
  • Hopfe M, Hoffmann R, Henrich BP, et al. P80, the HinT interacting membrane protein, is a secreted antigen of Mycoplasma hominis. BMC Microbiol. 2004;4:46.
  • Bumgardner EA, Kittichotirat W, Bumgarner RE, et al. Comparative genomic analysis of seven Mycoplasma hyosynoviae strains. Microbiologyopen. 2015;4:343–359.
  • Kwon AR, Kim JH, Park SJ, et al. Structural and biochemical characterization of HP0315 from Helicobacter pylori as a VapD protein with an endoribonuclease activity. Nucleic Acids Res. 2012;40:4216–4228.
  • Hata E, Nagai K, Murakami K. Mutations associated with change of susceptibility to lincosamides and/or macrolides in field and laboratory-derived Mycoplasma californicum strains in Japan, and development of a rapid detection method for these mutations. Vet Microbiol. 2019;229:81–89.
  • Bébéar CM, Renaudin H, Charron A, et al. Alterations in topoisomerase IV and DNA gyrase in quinolone-resistant mutants of Mycoplasma hominis obtained in vitro. Antimicrob Agents Chemother. 1998;42:2304–2311.
  • Chylinski K, Le Rhun A, Charpentier E. The tracrRNA and Cas9 families of type II CRISPR-Cas immunity systems. RNA Biol. 2013;10:726–737.
  • Burmistrz M, Pyrć K. CRISPR-Cas systems in prokaryotes. Pol J Microbiol. 2015;64:193–202.
  • Kumar S, Stecher G, Peterson D, et al. MEGA-CC: Computing core of molecular evolutionary genetics analysis program for automated and iterative data analysis. Bioinformatics. 2012;28:2685–2686.